Hydrocodone controlled release - Pain TherapeuticsAlternative Names: PTI 721
Latest Information Update: 09 May 2016
At a glance
- Originator DURECT Corporation
- Developer Pain Therapeutics
- Class Antitussives; Morphinans; Opioid analgesics; Opioid peptides; Small molecules
- Mechanism of Action Opioid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Suspended Pain